Clinical Trials for Squamous Cell Carcinoma of Head and Neck

Find clinical trials for squamous cell carcinoma of head and neck. Discover research opportunities and treatment options in your area.

41 Active Trials Found

Showing 41 trials on this page

Page 1 of 3

Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck

NCT ID: NCT05845307

This clinical trial is investigating a new treatment called TTI-101 for patients with HPV-negative squamous cell carcinoma of the head and neck, specifically those whose cancer is at Stage II-IV an...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Houston, Texas, United States

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT ID: NCT05544929

This clinical trial is exploring the safety and effectiveness of a new treatment called KFA115, both on its own and in combination with another medication called pembrolizumab, for patients with ce...

Clinical Trials for Squamous Cell Carcinoma of Head and Neck

41 Active Trials Found

Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients

A Beta-only IL-2 ImmunoTherapY Study

Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

A Study of SGN-B6A in Advanced Solid Tumors

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors

Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers

Pembrolizumab Plus Olaparib in LA-HNSCC

App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy

The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC

A Study of MGC026 in Participants With Advanced Solid Tumors

A Study Evaluating AB248 Alone or in Combination with Pembrolizumab in Adult Patients with Solid Tumors

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy

A Study of DM005 in Patients With Advanced Solid Tumors

Related Conditions